Krystal Biotech Inc (KRYS)

SG&A Expenses

$159.72M

TTM · Period ending: · USD

KRYS logo

KRYS SG&A Expenses

Latest reported$159.72M
KRYS TTM SG&A Expenses ($1.56M → $159.72M)
High-resolution chart · PNG

KRYS sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Krystal Biotech Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
159,722,000
155,032,000
146,741,000
136,749,000
127,884,000
120,350,000
113,685,000
105,654,000
100,638,000
98,916,000
96,893,000
97,666,000
93,904,000
85,863,000
77,183,000
66,020,000
55,657,000
47,593,000
40,390,000
32,271,000
27,279,000
20,795,000
15,064,000
12,121,000
8,998,000
7,357,000
6,463,000
6,075,000
5,676,000
4,926,000
4,156,000
3,149,000
2,829,000
2,174,000
1,563,000
1,371,000
714,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.